Medical Weight Loss for Johnson City, Tennessee Residents

Johnson City, Tennessee residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Johnson City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Tennessee: there is no local Johnson City office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Johnson City Residents Choose New Hope Weight Loss

New Hope keeps the money part simple so you can focus on the health part. For Johnson City patients that means semaglutide from $166 monthly, tirzepatide from $233 monthly, a $119 physician visit, no insurance required, and no penalty for living outside Costa Mesa. We take HSA, FSA, Klarna, and Affirm, so paying out of pocket does not have to mean paying all at once. Clear terms, no games.

Johnson City residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Johnson City address.

Telehealth is what lets us care for Johnson City, Tennessee from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout downtown Johnson City and the Tri-Cities of northeast Tennessee. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Johnson City.

There are no local-office hours to fit your life around, so Johnson City patients can meet Dr. Sharma on evenings or between work without crossing town. Tirzepatide, which shares its active ingredient with Mounjaro and Zepbound, starts at $233 per month for Johnson City patients and is billed apart from the $119 visit. Tennessee is one of the fastest-growing states in the South, and New Hope Weight Loss serves patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Johnson City meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Johnson City

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Johnson City address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Johnson City

Where is the New Hope Weight Loss location serving Johnson City?

The location serving Johnson City is our Costa Mesa, California clinic, which is our only physical site. We care for Johnson City, Tennessee patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Johnson City patients?

It is the standard for Johnson City. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Johnson City in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Johnson City patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Johnson City patients.

What areas of Johnson City do you serve?

We serve patients from across Johnson City by telehealth, including downtown Johnson City and the Tri-Cities of northeast Tennessee.

Are there hidden fees for Johnson City patients?

No. Johnson City patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Johnson City Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Johnson City, Tennessee by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.